Peptides and peptidomimetics having anti-proliferative activity and their use

Details for Australian Patent Application No. 2003235576 (hide)

Owner Takeda Pharmaceutical Company Limited

Inventors Kobayashi, Hidetaka; Kawabe, Takumi

Agent Freehills

Pub. Number AU-B-2003235576

PCT Number PCT/IB03/00425

PCT Pub. Number WO2003/059942

Priority 60/350,208 17.01.02 US

Filing date 17 January 2003

Wipo publication date 30 July 2003

Acceptance publication date 29 January 2009

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 33/24 (2006.01) Medicinal preparations containing inorganic active ingredients - Heavy metals

A61K 38/55 (2006.01) Medicinal preparations containing peptides - Protease inhibitors

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61K 51/08 (2006.01) Preparations containing radioactive substances for use in therapy or testing

A61P 35/00 (2006.01) Antineoplastic agents

A61P 35/04 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07K 5/06 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 5/065 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 7/02 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

C07K 7/06 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

C07K 7/08 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

Event Publications

4 September 2003 Application Open to Public Inspection

  Published as AU-B-2003235576

4 September 2003 Complete Application Filed

  Priority application(s): 60/350,208 17.01.02 US

7 October 2004 Amendment Made

  The nature of the amendment is: Amend the invention title to Peptides and peptidomimetics having antiproliferative activity and/or that augment nucleic acid damaging agents or treatments

20 December 2007 Assignment before Grant

  CanBas Co. Ltd. The application has been assigned to Takeda Pharmaceutical Company Limited

29 January 2009 Application Accepted

  Published as AU-B-2003235576

12 February 2009 Corrigenda

  Applications Accepted - Name Index Under the name Takeda Pharmaceutical Company Limited, Application No. 2003235576, under INID(54), correct the title to Peptides and peptidomimetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments

28 May 2009 Standard Patent Sealed

16 July 2009 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 03 Jun 2009. Address for service in Australia - Freehills Patent & Trade Mark Attorneys Level 43 101 Collins Street Mebourne VIC 3000

10 December 2009 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 03 Jun 2009

23 June 2011 Assignment Registered

  Takeda Pharmaceutical Company Limited The patent has been assigned to CanBas Co., Ltd.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003235577-IDENTIFICATION OF SMALL RUMINANTS

2003235575-FERROUS ARTICLES SINTERED USING A FLUIDIZED BED